NEW YORK, Sept. 10, 2020 /PRNewswire/ --
Cellular Biomedicine Group, Inc. CBMG
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of CBMG to members of CBMG management.
If you are a CBMG investor, and would like additional information about our investigation, please complete the Information Request Form.
GCI Liberty, Inc. GLIBA - Liberty Broadband Corporation (NASDAQ GS: LBRDK)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of GLIBA to Liberty Broadband Corporation (NASDAQ GS: LBRDK).
If you are a GLIBA or LBRDK investor, and would like additional information about our investigation, please complete the Information Request Form.
Jernigan Capital, Inc. JCAP
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of JCAP to an affiliate of NexPoint Advisors, L.P. for $17.30 per share.
If you are a JCAP investor, and would like additional information about our investigation, please complete the Information Request Form.
Maxim Integrated Products MXIM – Analog Devices ADI
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the proposed merger of MXIM and ADI.
If you are a MXIM or ADI investor, and would like additional information about our investigation, please complete the Information Request Form.
National General Holdings Corp. NGHC
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of NGHC to Allstate Corporation for $32.00 in cash and closing dividends expected to be $2.50 per share.
If you are a NGHC investor, and would like additional information about our investigation, please complete the Information Request Form.
Otelco Inc. OTEL
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of OTEL to of Oak Hill Capital for $11.75 per share.
If you are an OTEL investor, and would like additional information about our investigation, please complete the Information Request Form.
Pfenex Inc. PFNX
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of PFNX to Ligand Pharmaceuticals Incorporated.
If you are a PFNX investor, and would like additional information about our investigation, please complete the Information Request Form.
Spring Bank Pharmaceuticals, Inc. SBPH
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of SBPH to F-star Therapeutics, Limited.
If you are a SPBH investor, and would like additional information about our investigation, please complete the Information Request Form.
Varian Medical Systems, Inc. VAR
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of VAR to Siemens Healthineers AG for $177.50 per share.
If you are a VAR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
ATTORNEY ADVERTISING.© 2020 Lifshitz Law Firm, P.C. The law firm responsible for this advertisement is Lifshitz Law Firm, P.C., 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz Law Firm, P.C.
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: info@jlclasslaw.com
SOURCE Lifshitz & Miller Law Firm
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
